US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P 500 Equal Weight Health Care ETF

37.59

+0.63001.70%

Post-market: 37.590.00000.00%19:30 EDT

Volume:166.37K

Turnover:6.25M

Market Cap:897.27M

PE:- -

High:37.65

Open:37.00

Low:37.00

Close:36.96

52wk High:38.19

52wk Low:29.46

Shares:23.87M

Float Shares:23.87M

Volume Ratio:0.69

T/O Rate:0.70%

Dividend:0.22

Dividend Rate:0.59%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Lantheus announces CMS granted TPT payment status for PYLARIFY TruVu injection

Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations

2026 Nobel Prize Preview: Scientists Behind GLP-1 Weight-Loss Drugs Emerge as Leading Contenders

Lonza Strengthens Board with Nomination of Biotech Veteran Pearl Huang

Actinogen Medical Adds Modest Number of New Shares to ASX Listing

Marvel Biosciences Raises $1.6 Million to Advance Lead Neurology Drug Into Phase 1 Trials

Shenzhen Lifotronic Technology Secures Medical Device Registration Certificate for Photon Therapeutic Apparatus

Rhythm Biosciences Files Updated Corporate Governance Statement With ASX

Singular Health Secures Florida Medicaid Imaging Repository Deal With FIU

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

Singular Health set to land $3.5M slice of Florida Medicaid imaging play

The West Australian

Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M

Healthcare Shows Resilience! Pharma ETF Huabao (562050) Rises Against the Market, Livzon Pharmaceutical Group Hits Limit Up! Medical Devices Show Localized Strength, Mindray and United Imaging Advance Together

EBR Systems advances FDA approval process for new WiSE manufacturing site

Millions Will Lose Medicaid Once New Work Rules Kick In. These Groups Will be Hit the Hardest.

ADARx Pharmaceuticals indicated to open at $28, IPO priced at $17

Millions Will Lose Medicaid Once New Work Rules Kick In. These Groups Will be Hit the Hardest.

Huihe Medical's STAR Market IPO Application Terminated; Company Focuses on Innovative Medical Devices in Panvascular Intervention

Lifetech Scientific's SureCham Aortic Arch Single-Branch Stent Graft System Enters Special Review Pathway for Innovative Medical Devices

Bioperfectus Secures Two Medical Device Registration Certificates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/RSPH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":37.59,"timestamp":1791576000000,"preClose":36.96,"halted":0,"volume":166367,"hourTrading":{"tag":"盘后","latestPrice":37.59,"preClose":37.59,"latestTime":"19:30 EDT","volume":31,"amount":1165.0542,"timestamp":1791588606096,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.017045454545454614,"floatShares":23870000,"shares":23870000,"eps":0,"marketStatus":"Closed","change":0.63,"latestTime":"10-09 16:00:00 EDT","open":37,"high":37.65,"low":37,"amount":6245932.9177,"amplitude":0.017587,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":36.96,"sharesOutstanding":23410000,"nav":36.98074,"aum":875334115.8,"dividendRate":0.005901,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":36.96,"preClose":36.96,"latestTime":"07:58 EDT","volume":18,"amount":665.28,"timestamp":1791547121575,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":37.59,"preClose":37.59,"latestTime":"19:30 EDT","volume":31,"amount":1165.0542,"timestamp":1791588606096,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.689614,"impliedVol":0.0046,"impliedVolPercentile":0.0797},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":23870000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.689614,"shares":23870000,"dividePrice":0.2218,"high":37.65,"amplitude":0.017587,"preClose":36.96,"low":37,"week52Low":29.46,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":37.59,"eps":0,"divideRate":0.005901,"volume":166367,"delay":0,"ttmEps":0,"open":37,"prevYearClose":31.85,"prevWeekClose":36.62,"prevMonthClose":37.01,"prevQuarterClose":37.01,"fiveDayClose":36.62,"twentyDayClose":36.08,"sixtyDayClose":34.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"RSPH","amount":0.05159,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.04585,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671416202","title":"Lantheus announces CMS granted TPT payment status for PYLARIFY TruVu injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2671416202","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671416202?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:51","pubTimestamp":1790772680,"startTime":"0","endTime":"0","summary":"Lantheus (LNTH) Holdings announced that the Centers for Medicare & Medicaid Services, CMS, has granted Transitional Pass-Through, TPT, payment stat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lantheus-announces-cms-granted-tpt-payment-status-for-pylarify-truvu-injection-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lantheus-announces-cms-granted-tpt-payment-status-for-pylarify-truvu-injection-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","LNGR","BK4585","BK4198","BK4588","LNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671462201","title":"Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations","url":"https://stock-news.laohu8.com/highlight/detail?id=2671462201","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671462201?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:00","pubTimestamp":1790766000,"startTime":"0","endTime":"0","summary":"SINGAPORE and NORTH BRUNSWICK, N.J., Sept.  30, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Group Ltd. (NASDAQ: ANL) (“Adlai Nortye” or the “Company”), a clinical-stage biotechnology company focused on the ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3371738/0/en/adlai-nortye-appoints-christopher-liu-pharmd-as-head-of-investor-relations-and-public-relations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","LU0348723411.USD","LU1983260115.SGD","LU1548497426.USD","BK4605","ALN","LU2298322129.HKD","SYNB","BK4141","LU1854104046.USD","LU2357305700.SGD","IE00BZ199S13.USD","LU1861219969.SGD","ONX","IBB","LU1720051017.SGD","ONG","LU1861214812.USD","FHLC","ON","BK4588","LU0724618433.USD","IE00BD6J9T35.USD","LU1861215975.USD","LU2133065610.SGD","IEIH","BK4585","LU1861220033.SGD","LU2360107325.USD","JDOC","ANL","BBP","BK4139","BK4512","IE00BFMHRM44.USD","LU1720051108.HKD","LU1978683503.SGD","LU0124384867.USD","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176833437","title":"2026 Nobel Prize Preview: Scientists Behind GLP-1 Weight-Loss Drugs Emerge as Leading Contenders","url":"https://stock-news.laohu8.com/highlight/detail?id=1176833437","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176833437?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:00","pubTimestamp":1790755226,"startTime":"0","endTime":"0","summary":"The 2026 Nobel Prize laureates will be announced successively from October 5 to 12. In order to understand the list of hot candidates, The Scientist published scientists' predictions for the 2026...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIS","FXH","PJP","ELIL","CURE","RSPH","OZEM","LLYX","FHLC","NVOH","NBDS","PINK","THNR","MEDI","JDOC","NVOX","LLII","TRUH","IYH","NVOC","XLVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671278331","title":"Lonza Strengthens Board with Nomination of Biotech Veteran Pearl Huang","url":"https://stock-news.laohu8.com/highlight/detail?id=2671278331","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671278331?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:32","pubTimestamp":1790746351,"startTime":"0","endTime":"0","summary":"The latest update is out from Lonza Group Ltd ( ($CH:LONN) ). Lonza has nominated pharmaceutical and biotechnology veteran Pearl Huang as an indepe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lonza-strengthens-board-with-nomination-of-biotech-veteran-pearl-huang?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lonza-strengthens-board-with-nomination-of-biotech-veteran-pearl-huang?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","BK4581","SYNB","JDOC","BK4585","BK4588","DARP","IBB","XBI","FHLC","AGNG","XT","RSPH","FWD","IEIH","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222612","title":"Actinogen Medical Adds Modest Number of New Shares to ASX Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671222612?lang=en_us&edition=fundamental","pubTime":"2026-09-30 11:17","pubTimestamp":1790738242,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) has provided an announcement. Actinogen Medical Limited, an ASX-listed biotechnology company, has its ordinary full...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-adds-modest-number-of-new-shares-to-asx-listing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-adds-modest-number-of-new-shares-to-asx-listing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","RSPH","IEIH","JDOC","XT","BBP","AGNG","SYNB","IBB","BK4585","DARP","FWD","BK4588","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671122851","title":"Marvel Biosciences Raises $1.6 Million to Advance Lead Neurology Drug Into Phase 1 Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2671122851","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671122851?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:32","pubTimestamp":1790721144,"startTime":"0","endTime":"0","summary":"An update from Marvel Biosciences Corp ( ($TSE:MRVL) ) is now available. Marvel Biosciences Corp., a Calgary-based pre-clinical biotechnology compa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-raises-1-6-million-to-advance-lead-neurology-drug-into-phase-1-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-raises-1-6-million-to-advance-lead-neurology-drug-into-phase-1-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","IBB","LNGR","XT","DBB","FHLC","AGNG","IEIH","FWD","JDOC","RSPH","DARP","BBP","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101970069","title":"Shenzhen Lifotronic Technology Secures Medical Device Registration Certificate for Photon Therapeutic Apparatus","url":"https://stock-news.laohu8.com/highlight/detail?id=1101970069","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101970069?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:29","pubTimestamp":1790674165,"startTime":"0","endTime":"0","summary":"Shenzhen Lifotronic Technology Co.,Ltd. (688389.SH) has announced that its controlling subsidiary, Chongqing Lifotronic Biotechnology Co., Ltd., recently received the Medical Device Registration...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","PTH","MEDX","HART","MDEV","RSPH","LGHT","BK0251","BK1100","LNGR","688389","BK1574","AGNG","GDOC","09996","159883","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671299437","title":"Rhythm Biosciences Files Updated Corporate Governance Statement With ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2671299437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671299437?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:13","pubTimestamp":1790665987,"startTime":"0","endTime":"0","summary":"An announcement from Rhythm Biosciences Ltd. ( ($AU:RHY) ) is now available. Rhythm Biosciences Ltd., an Australian biotechnology company, operates...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rhythm-biosciences-files-updated-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rhythm-biosciences-files-updated-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","SYNB","BK4588","DARP","FHLC","FWD","IEIH","BBP","BK4585","JDOC","RSPH","AGNG","IBB","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671426325","title":"Singular Health Secures Florida Medicaid Imaging Repository Deal With FIU","url":"https://stock-news.laohu8.com/highlight/detail?id=2671426325","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671426325?lang=en_us&edition=fundamental","pubTime":"2026-09-29 06:46","pubTimestamp":1790635563,"startTime":"0","endTime":"0","summary":"An update from Singular Health Group Ltd ( ($AU:SHG) ) is now available. Singular Health Group has signed an amended memorandum of understanding wi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/singular-health-secures-florida-medicaid-imaging-repository-deal-with-fiu?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/singular-health-secures-florida-medicaid-imaging-repository-deal-with-fiu?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671125702","title":"Teva announces FDA approval of Degevma as a biosimilar to Xgeva","url":"https://stock-news.laohu8.com/highlight/detail?id=2671125702","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671125702?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:05","pubTimestamp":1790625914,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceutical Industries announced that the FDA has approved Degevma as a biosimilar to Xgeva. Degevma is indicated for the prevention...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","FRTY","BK4585","BK4559","MRNX","IDNA","XLVX","IBB","MEDI","BK4557","BBP","LU1983299246.USD","BK4007","RSPH","LABU","IYH","LU2324357040.USD","TBXU","LFSC","PSCH","BMED","TECB","TEVA","IEIH","GNMX","BK4588","BK4584","GDOC","SYNB","MRNY","PINK","NVIB","BK4596"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671260681","title":"Singular Health set to land $3.5M slice of Florida Medicaid imaging play","url":"https://stock-news.laohu8.com/highlight/detail?id=2671260681","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671260681?lang=en_us&edition=fundamental","pubTime":"2026-09-29 03:48","pubTimestamp":1790624934,"startTime":"0","endTime":"0","summary":"Singular Health Group is set to pocket a $3.5m share of a major Florida Medicaid imaging project, worth the equivalent of 2.5 times its FY26 revenue, to build a state-funded imaging repository.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-22941883/2ddbfd39778760c9c49284a0edd085a3c3abd66d.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22941883/2ddbfd39778760c9c49284a0edd085a3c3abd66d.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/singular-health-set-to-land-35m-slice-of-florida-medicaid-imaging-play-c-22941883","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/singular-health-set-to-land-35m-slice-of-florida-medicaid-imaging-play-c-22941883","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["RSPH","BK4185","PACS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236928","title":"Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236928","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670236928?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:10","pubTimestamp":1790590220,"startTime":"0","endTime":"0","summary":"With the completion of the Theravance Biopharma acquisition and the receipt of the U.S. FDA approval of Ziihera for first-line HER2-positive advanc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","BK4588","TECB","LABU","MRNX","XLVX","TBXU","PSCH","BK4007","PINK","GDOC","IEIH","BK4585","IYH","BMED","RSPH","LFSC","TBPH","BBP","MEDI","IBB","NVIB","SYNB","MRNY","FRTY","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132272624","title":"Healthcare Shows Resilience! Pharma ETF Huabao (562050) Rises Against the Market, Livzon Pharmaceutical Group Hits Limit Up! Medical Devices Show Localized Strength, Mindray and United Imaging Advance Together","url":"https://stock-news.laohu8.com/highlight/detail?id=1132272624","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132272624?lang=en_us&edition=fundamental","pubTime":"2026-09-28 13:22","pubTimestamp":1790572929,"startTime":"0","endTime":"0","summary":"On the first trading day after the Mid-Autumn Festival (September 28), A-shares underwent a deep correction, with the Shanghai Composite Index falling nearly 2% at one point. Pharmaceutical assets...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK0028","BK1574","159883","BK1100","BK1515","BK1583","IEIH","LGHT","BK0187","HART","RSPH","562050","GDOC","MEDX","BK1161","LNGR","BK0239","MDEV","PTH","AGNG","159938","BK0188","000513","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402990","title":"EBR Systems advances FDA approval process for new WiSE manufacturing site","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402990","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402990?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:08","pubTimestamp":1790554084,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:EBR) ). EBR Systems, developer of the WiSE wi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ebr-systems-advances-fda-approval-process-for-new-wise-manufacturing-site?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","LABU","FRTY","LFSC","IYH","PSCH","BBP","SYNB","IBB","XLVX","BK4588","TBXU","PINK","MEDI","BK4585","TECB","BMED","NVIB","GNMX","MRNX","RSPH","IEIH","GDOC","EES","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670474122","title":"Millions Will Lose Medicaid Once New Work Rules Kick In. These Groups Will be Hit the Hardest.","url":"https://stock-news.laohu8.com/highlight/detail?id=2670474122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670474122?lang=en_us&edition=fundamental","pubTime":"2026-09-26 23:31","pubTimestamp":1790436660,"startTime":"0","endTime":"0","summary":"The changes will cut about $1 trillion from federal Medicaid spending over 10 yearsMore than 66% of applicable Medicaid recipients are in the labor force, but getting sufficient work hours to qualify ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670099423","title":"ADARx Pharmaceuticals indicated to open at $28, IPO priced at $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2670099423","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670099423?lang=en_us&edition=fundamental","pubTime":"2026-09-25 22:25","pubTimestamp":1790346339,"startTime":"0","endTime":"0","summary":"ADARx Pharmaceuticals (ADRX), a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, priced its upsized initial...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adarx-pharmaceuticals-indicated-to-open-at-28-ipo-priced-at-17-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adarx-pharmaceuticals-indicated-to-open-at-28-ipo-priced-at-17-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","FRHC","JDOC","BK4588","ADRX","BK4585","FHLC","DARP","IBB","BBP","IEIH","REDS","XT","FWD","SYNB","IPOS","RSPH","KCE","AGNG","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669499041","title":"Millions Will Lose Medicaid Once New Work Rules Kick In. These Groups Will be Hit the Hardest.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669499041","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669499041?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:50","pubTimestamp":1790261400,"startTime":"0","endTime":"0","summary":"The changes will cut about $1 trillion from federal Medicaid spending over 10 yearsMore than 66% of applicable Medicaid recipients are in the labor force, but getting sufficient work hours to qualify ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193610255","title":"Huihe Medical's STAR Market IPO Application Terminated; Company Focuses on Innovative Medical Devices in Panvascular Intervention","url":"https://stock-news.laohu8.com/highlight/detail?id=1193610255","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193610255?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:54","pubTimestamp":1790254489,"startTime":"0","endTime":"0","summary":"Huihe Medical's STAR Market IPO review status was changed to \"terminated\" on September 24, as the company and its sponsor withdrew the listing application, according to the relevant provisions of the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","RSPH","IEIH","BK1100","LGHT","HART","REDS","BK1574","09996","LNGR","159891","BK4127","MDEV","MEDX","KSTR","FRHC","KCE","AGNG","GDOC","159883","PTH","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104658454","title":"Lifetech Scientific's SureCham Aortic Arch Single-Branch Stent Graft System Enters Special Review Pathway for Innovative Medical Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1104658454","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104658454?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:16","pubTimestamp":1790252179,"startTime":"0","endTime":"0","summary":"Lifetech Scientific (01302) has announced that on September 24, 2026, the company received formal written notification from the National Medical Products Administration confirming that the SureCham...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","BK1583","159883","01302","BK1600","BK1100","HART","MDEV","MEDX","AGNG","IEIH","09996","GDOC","RSPH","BK1574","LNGR","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131609096","title":"Bioperfectus Secures Two Medical Device Registration Certificates","url":"https://stock-news.laohu8.com/highlight/detail?id=1131609096","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131609096?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:20","pubTimestamp":1790241617,"startTime":"0","endTime":"0","summary":"Bioperfectus Technologies (688399.SH) announced that it has recently received medical device registration certificates (in vitro diagnostic reagents) issued by the National Medical Products...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","GDOC","BK0239","MDEV","AGNG","09996","HART","688399","RSPH","LGHT","LNGR","PTH","IEIH","159883","BK1574","MEDX","BK1100"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}